Marché mondial du traitement de la cryptosporidiose – Tendances et prévisions de l’industrie jusqu’en 2028

Analyse et perspectives du marché : marché mondial du traitement de la cryptosporidiose

Le marché du traitement de la cryptosporidiose devrait connaître une croissance du marché au cours de la période de prévision 2021-2028. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 5,30 % au cours de la période de prévision mentionnée ci-dessus.

La cryptosporidiose est une infection parasitaire causée par des parasites appelés Cryptosporidium. Ces parasites se trouvent dans le sol, l'eau, les aliments ou les surfaces contaminés par les excréments d'animaux ou d'humains infectés. Ils se transmettent d'une personne à une autre, d'un animal à une autre et par l'ingestion d'aliments ou d'eau contaminés. Les signes et symptômes de cette maladie infectieuse sont la fièvre , la diarrhée aqueuse, le manque d'appétit, les crampes d'estomac, la perte de poids, les nausées, les vomissements et la déshydratation. Cette maladie est également connue sous le nom de crypto.

L’augmentation de la prévalence de la cryptosporidiose et l’adoption d’une bonne hygiène de santé sont les principaux facteurs influençant le taux de croissance du marché. En outre, l’augmentation des dépenses de santé , les progrès de la technologie médicale, l’augmentation du financement gouvernemental et les initiatives croissantes des organisations publiques et privées pour faire connaître les mesures préventives sont les facteurs qui permettront d’élargir le marché du traitement de la cryptosporidiose.

L’augmentation des activités de recherche et développement et les essais cliniques en cours offriront des opportunités bénéfiques pour le marché du traitement de la cryptosporidiose au cours de la période de prévision 2021-2028.

However, high cost of treatment and complications associated with the cryptosporidiosis such as severe dehydration, significant weight loss and inflammation are the factors that will hinder the market growth. Lack of awareness about the disease, its preventive measures, and the adverse effects of medications will challenge the cryptosporidiosis treatment market in the forecast period mentioned above.

This cryptosporidiosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cryptosporidiosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cryptosporidiosis Treatment Market Scope and Market Size

The cryptosporidiosis treatment market is segmented on the basis of treatment, diagnosis, symptoms, mode of transmission, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the cryptosporidiosis treatment market is segmented into anti-parasitic drugs, anti-mobility agents, antiretroviral therapies, fluid replacement and others.
• On the basis of diagnosis, the cryptosporidiosis treatment market is segmented into acid-staining test, stool culture and others.
• On the basis of symptoms, the cryptosporidiosis treatment market is segmented into fever, watery diarrhea, lack of appetite, stomach cramps, weight loss, nausea, vomiting, dehydration and others. 
• On the basis of mode of transmission, the cryptosporidiosis treatment market is segmented into person to person, animal to person and ingestion of contaminated food or water.
• On the basis of dosage, the cryptosporidiosis treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the cryptosporidiosis treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the cryptosporidiosis treatment market is segmented into clinic, hospital and others.

The cryptosporidiosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Cryptosporidiosis Treatment Market Country Level Analysis

Cryptosporidiosis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, symptoms, mode of transmission, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the cryptosporidiosis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cryptosporidiosis treatment market due to the presence of major key players, growing investment for R&D activities, high disposable income, and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, improvements in the healthcare infrastructure and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cryptosporidiosis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cryptosporidiosis Treatment Market Share Analysis

Le paysage concurrentiel du marché du traitement de la cryptosporidiose fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais cliniques, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée à la recherche sur le marché mondial du traitement de la cryptosporidiose.

Français Les principaux acteurs couverts dans le rapport sur le marché du traitement de la cryptosporidiose sont Merck KGaA, Pfizer Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Novartis AG, Bayer AG, F. Hoffmann-La Roche Ltd., Zydus Cadila, Dr. Reddy's Laboratories Ltd., Sanofi, AstraZeneca, Alkem Labs, Ipca Laboratories Ltd., Cipla Inc., Alvizia Healthcare Private Limited, Arbor Pharmaceuticals, Mankind Pharma, Mylan NV, Merck Sharp & Dohme Corp., Mallinckrodt., entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-66872